AT
Ashish Kumar Tripathi
Indian Institute of Technology Bhilai, Emory University, Central Drug Research Institute, CSIR-Central Drug Research Institute
0000-0002-0976-8476
Employment
-
Indian Institute of Technology Bhilai Assistant Professor2025 - Present
-
Emory University Postdoc Fellow2022 - 2025
-
CSIR-Central Drug Research Institute2015 - 2022
Education
-
Central Drug Research Institute Doctor of Philosophy
Projects & Funding
Projects & funding information is unavailable.
Publications (25)
- IL-4 Correlates With Bone Mineral Density in Men, and IL-4 Depletion May Drive Bone Loss in Men With HIV Save
- Fortified Withaferin A accelerates the transition from fibrovascular to bone remodeling phase during endochondral bone formation to promote ossification Save
- miR4352b a cross-species modulator of SOSTDC1, targets dual pathway to regulate bone health and fracture healing Save
- Comparative assessment of flavonoid content in banana pulp and peel and their role in mitigating bone loss conditions and promoting osteoblast differentiation Save
- FDA-approved polypeptide PTH 1-34 impedes palmitic acid-mediated osteoblasts dysfunction by promoting its differentiation and thereby improving skeletal health Save
- Combined Sequential Antiretroviral Therapy-Induced Immune Reconstitution Bone Loss and Estrogen Deficiency Bone Loss are Cumulative in Mice Models Save
- Hydroxyurea blunts mitochondrial energy metabolism and osteoblast and osteoclast differentiation exacerbating trabecular bone loss in sickle cell mice Save
- Withaferin A Ameliorated the Bone Marrow Fat Content in Obese Male Mice by Favoring Osteogenesis in Bone Marrow Mesenchymal Stem Cells and Preserving the Bone Mineral Density Save
- Alendronate-functionalized porous nano-crystalsomes mitigate osteolysis and consequent inhibition of tumor growth in a tibia-induced metastasis model. Save
- Linoleic acid blunts early osteoblast differentiation and impairs oxidative phosphorylation in vitro Save